AzTrials
AzTrials

Computed TomographyNCT07275281

Incidental Findings on Coronary Computed Tomography Angiography

An observational study of Computed Tomography and Coronary Angiography, run by Jordan Collaborating Cardiology Group at 1 site in Jordan.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Coronary CT angiography (CCTA) is increasingly used for ischemic heart disease diagnosis. The rising number of CCTA tests has led to a significant increase in the number of finding unexpected incidental extracardiac diseases. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
CCTA (Review of the scans)
How many people
2,000 participants
Where
1 siteJordan
Study dates
2 Jan 2026to 28 Feb 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: 1. All adult patients who underwent CCTA for chest pain diagnosis. 2. Scans will be reviewed seeking the presence of coronary non atherosclerotic disease in the coronaries, cardiac structure and non cardiac structures.

Who may be able to join

  • Adult patients ho underwent CCTA

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Wasfi Alghween, MD contact

+96265001000

hammoudeh_ayman@yahoo.com

Musa Saadeh contact

065001000

Jordan1 site
  • Istishari Hospital

    Amman, 11184

    Ayman Hammoudeh, MD, FACC, 065001000, hammoudeh_ayman@yahoo.com

    Wasfi Alghween, MD, 065001000

Other trials in Jordan

About this study

Official title: Incidental Noncardiac Findings on Coronary Computed Tomography Angiography

Coronary CT angiography (CCTA) is increasingly used for ischemic heart disease diagnosis. The rising number of CCTA tests has led to a significant increase in the number of finding unexpected incidental extracardiac diseases.

Read the detailed description

The increasing utilization of coronary computed tomography (CT) angiography (CCTA) to diagnose and triage patients with suspected or known ischemic heart disease has led to a parallel increase in the frequency of incidental findings in the coronaries (nonatherosclerotic), noncoronary cardiac structures and noncardiac structures.

Studies have reported a prevalence of incidental findings on CCTA up to 40%. Most of these findings have no clinical relevance, but some have significant clinical implications in the care and prognosis of the patients.

We sought to assess the frequency of incidental findings on CCTA scans in consecutive studies performed in the past 5 years.

Being tested
CCTA (Review of the scans)
Keywords
Coronary artery disease, computed tomography, indidental findings
Medical subject headings
Coronary Artery Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CCTA (Review of the scans)Diagnostic test

    Reviewing coronary scans done in the past 5 years looking for findings other than atherosclerotic coronary artery disease.

Study groups in NCT07275281
Study groupRoleWhat they receive
Adult patients who underwent CCTAAll adults (18 years of age and older0 who underwent CCTA to evaluate the coronary arteries in the past 5 years will have their CT scans reviewed for the presence of non coronary incidental findings.
Receives: Diagnostic Test: CCTA (Review of the scans)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Non atherosclerotic coronary disease

    Findings other than coronary atherosclerotic disease: coronary bridge, coronary dissection, coronary embolism, and coronary fistula.

    Measured: BASELINE

  2. Non coronary cardiac findings

    Findings include valve calcifications, left atrial appendage thrombus, patent foramen ovale and septal defects, pericardial effusion, LV clots, cardiac tumors.

    Measured: BASELINE

  3. Non cardiac findings

    Non cardiac findings include: a. major vascular abnormalities in the aorta and the pulmonary arteries, b. pulmonary disease: masses, lymph nodes, granulomas, and pleural effusion, and c. non pulmonary findings in the diaphragm and the hepatobiliary tree.

    Measured: BASELINE

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2025
  2. Study start2 Jan 2026 (estimated)
  3. Primary completion2 Jan 2027 (estimated)
  4. Study completion28 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
2,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07275281
Sponsor's protocol ID
JOINCIDENT.CCTA.NOV2025/3
Status last verified
Dec 2025
First submitted
28 Nov 2025
Last updated
30 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The excel sheet of the incidental findings in the 2000 CCTA scans in possession of the investigators will be available to any physician upon request

Questions about this trial

What is this clinical trial studying?

An observational study of Computed Tomography and Coronary Angiography, run by Jordan Collaborating Cardiology Group at 1 site in Jordan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 30 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Jordan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Wasfi Alghween, MD (+96265001000, hammoudeh_ayman@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Non atherosclerotic coronary disease (time frame: BASELINE). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Dec 2025; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in